FDA Rounded out 2019 by Approving a New Treatment for Pancreatic Cancer
In the final days of 2019, the U.S. Food and Drug Administration (FDA) expanded the use of a previously...
In the final days of 2019, the U.S. Food and Drug Administration (FDA) expanded the use of a previously...
On Wednesday, the U.S. Food and Drug Administration (FDA) expanded the use of the molecularly targeted therapeutic niraparib (Zejula)...
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...